• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

当前和新兴的治疗方法以满足未满足的 MDD 需求。

Current and Emerging Treatments to Address Unmet Needs in MDD.

机构信息

Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

出版信息

J Clin Psychiatry. 2019 Jan/Feb;80(1). doi: 10.4088/JCP.AL18009BR1C.

DOI:10.4088/JCP.AL18009BR1C
PMID:30865787
Abstract

Most people who experience a depressive episode are greatly impaired by it. No one-size-fits-all therapy is available, and most patients require multiple treatment steps. Check out this CME activity to learn about current and emerging strategies for managing MDD.

摘要

大多数经历过抑郁发作的人都会受到严重影响。目前尚无一种适用于所有人的疗法,大多数患者需要采取多个治疗步骤。请查看本次 CME 活动,了解目前和新出现的治疗 MDD 的策略。

相似文献

1
Current and Emerging Treatments to Address Unmet Needs in MDD.当前和新兴的治疗方法以满足未满足的 MDD 需求。
J Clin Psychiatry. 2019 Jan/Feb;80(1). doi: 10.4088/JCP.AL18009BR1C.
2
Why is mechanism of action important in antidepressant treatment?抗抑郁治疗中作用机制为何重要?
J Clin Psychiatry. 2016 May;77(5):e603. doi: 10.4088/JCP.14052cc3c.
3
The Concurrent Treatment With Intravenous Ketamine and an Irreversible Monoamine Oxidase Inhibitor for Treatment-Resistant Depression Without Hypertensive Crises.静脉注射氯胺酮与不可逆单胺氧化酶抑制剂联合治疗难治性抑郁症且无高血压危象。
J Clin Psychopharmacol. 2020 Sep/Oct;40(5):515-517. doi: 10.1097/JCP.0000000000001244.
4
The TNF-alpha inhibitor etanercept as monotherapy in treatment-resistant depression - report of two cases.肿瘤坏死因子-α抑制剂依那西普单药治疗难治性抑郁症——两例报告
Psychiatr Danub. 2014 Sep;26(3):288-90.
5
Identifying patients with depression who require a change in treatment and implementing that change.识别需要改变治疗方案的抑郁症患者并实施这种改变。
J Clin Psychiatry. 2016 Feb;77 Suppl 1:16-21. doi: 10.4088/JCP.14077su1c.03.
6
Guidelines for the recognition and management of mixed depression.混合性抑郁症的识别与管理指南
CNS Spectr. 2017 Apr;22(2):203-219. doi: 10.1017/S1092852917000165. Epub 2017 Feb 28.
7
Remission and Treatment Augmentation of Depression in the United States.美国抑郁症的缓解与治疗强化
J Clin Psychiatry. 2021 Nov 2;82(6):21m13988. doi: 10.4088/JCP.21m13988.
8
Antidepressant response and subthreshold bipolarity in "unipolar" major depressive disorder: implications for practice and drug research.“单相”重度抑郁症中的抗抑郁反应与阈下双相性:对临床实践和药物研究的启示
J Clin Psychopharmacol. 2013 Aug;33(4):449-52. doi: 10.1097/JCP.0b013e318299d2d5.
9
Understanding the genetic aspects of resistance to antidepressants treatment.理解抗抑郁药治疗抵抗的遗传方面。
Eur Rev Med Pharmacol Sci. 2020 Jul;24(14):7784-7795. doi: 10.26355/eurrev_202007_22281.
10
Intravenous ketamine for treatment-resistant major depressive disorder.静脉注射氯胺酮治疗难治性重度抑郁症。
Ann Pharmacother. 2012 Jan;46(1):117-23. doi: 10.1345/aph.1Q371. Epub 2011 Dec 20.

引用本文的文献

1
A new direction for adjunctive therapy of difficult-to-treat depression: examining the role of orexin receptor antagonists.难治性抑郁症辅助治疗的新方向:探讨食欲素受体拮抗剂的作用
Eur Arch Psychiatry Clin Neurosci. 2025 May 28. doi: 10.1007/s00406-025-01999-w.
2
A Meta-Analysis of the Antidepressant Responses in Pivotal Trials on Esketamine Nasal Spray and Atypical Antipsychotics.艾氯胺酮鼻喷雾剂与非典型抗精神病药物关键试验中抗抑郁反应的Meta分析。
Neuropsychiatr Dis Treat. 2023 Dec 27;19:2857-2870. doi: 10.2147/NDT.S417027. eCollection 2023.